Cooperative Agreement U18DP006289

This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $277,540 to The Nemours Foundation to conduct a longitudinal observational study on the cognitive, structural, and functional impact of new-onset type 1 diabetes on the brains of young children aged 4-10 years. The study aims to assess neurocognitive function, correlate it...

This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $840,420 to the University of California, Davis to conduct a longitudinal cohort study investigating the impact of type 1 diabetes (T1D) factors, such as diabetic ketoacidosis (DKA) and glycemic control, on neurocognitive outcomes in children. The study aims to characterize...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $813,788 Cooperative Agreement (Grant ID U01DK140776) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Washington University in St. Louis. The award, titled "UNITED: Understanding Neurocognitive Outcomes in Type 1 Diabetes: Modifiable Risk and Protective Factors in Diverse Youth", will support a longitudinal study examining the cognitive, functional, and...

This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to investigate the impact of type 1 diabetes (T1D) on brain development in pre-pubertal children. The $952,320 award to Joslin Diabetes Center, Inc. and Boston Children's Hospital will fund a 5-year study to recruit 600 children aged 4-8 with newly diagnosed T1D and 300 healthy...

This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to evaluate the real-world effectiveness and utilization of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in the treatment of type 2 diabetes in adolescents and young adults (AYAs). The $261,596 award to The Children's Hospital of Philadelphia Research Institute will fund a...

This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $786,393 to investigate the neurocognitive effects of Type 1 diabetes in young children. The study aims to: 1) better understand the impact of Type 1 diabetes on the developing brain, 2) identify risk and protective factors associated with neurocognitive effects, and 3) assess...

This $512,812 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports a pilot randomized trial to test the feasibility and preliminary efficacy of the T1CARE intervention. T1CARE aims to address social determinants of health for young adults with type 1 diabetes through comprehensive assessment, responsiveness, and engagement. The study will partner with a community-based...

This Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) will support research to describe retinal neurodegeneration in youth with type 1 and type 2 diabetes, as well as prediabetes. The $155,000 award to The Johns Hopkins University will fund a 2-year study using optical coherence tomography (OCT) imaging to measure retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in a cohort of 380 youth with diabetes, 25 with prediabetes, and 21 healthy...

This Cooperative Agreement award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will provide $887,675 to New York University School of Medicine to evaluate the neurocognitive complications of Type 1 diabetes (T1D) and potential risk/protective factors in pre-pubertal children. The research plan is to enroll up to 1,000 pre-pubertal children, half of whom were diagnosed with T1D within the...

This Cooperative Agreement award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will provide $1,028,969 to the University of Florida to conduct a comprehensive study on the impact of Type 1 Diabetes (T1D) on brain and neurocognitive development in children. The study aims to: 1) understand the impact of T1D on brain structure, neurocognitive, and psychosocial...